MyDoc is preparing the ground for its enterprise healthcare platform to launch in Asian markets like Sri Lanka or Hong Kong.

The spinout is working on a robotic arm for removing gastrointestinal cancer tumours without the need for an operational incision.

The EMBL Ventures-backed immunotherapy developer floated in an underpriced offering and received $20m in a private placement from NEA.

Give and Take has marked the beta release of its occupational networking platform Givitas, which aims to foster a giving culture in the workforce.

A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.

The Cambridge spinout is commercialising research into better techniques for extracting quality stem cells, having raised a reported $464,000 in seed funding.

Novo and Sanofi have backed a series A round for Inozyme Pharma, which is developing treatments for rare diseases affecting infants based on research at Yale.

SNHU has backed edtech developer Edmit through the Rethink Education fund, a vehicle also backed by Rethink Education.